Interventional Sonography Guided by Image Fusion

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05393102` - Auxiliary Diagnosis of Liver Nodules Using cfDNA Whole-genome Signatures
Recruiting	`NCT03871140` - Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis
Recruiting	`NCT04682886` - Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging
Completed	`NCT00243633` - Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)	N/A

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05393102 - Auxiliary Diagnosis of Liver Nodules Using cfDNA Whole-genome Signatures

Recruiting

NCT03871140 - Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis

Recruiting

NCT04682886 - Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging

Completed

NCT00243633 - Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00781924
Study type	Observational
Source	Rigshospitalet, Denmark
Contact
Status	Completed
Phase	N/A
Start date	January 2008
Completion date	September 2009

Interventional Sonography Guided by Image Fusion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms